Homburger advises Thermo Fisher on CHF bond issuance
Homburger advised American biotech multinational Thermo Fisher Scientific through successful completion of a Swiss law governed CHF 1.425 bn bond issuance.
The context
Consisting of five tranches, the operation marks the largest Swiss franc bond issuance from a US corporate in history.
As of today, the bonds have been provisionally admitted to trading. Application has been already filed for definitive admission to trading and listing of the bonds on the SIX Swiss Exchange.
The issuance saw participation from UBS Investment Bank, BNP Paribas (Suisse), and Deutsche Bank’s London Branch (acting through Deutsche Bank’s Zurich Branch), as lead managers.
The Homburger team
Homburger advised Thermo Fisher Scientific on all the legal, transactional and tax aspects of Swiss law. Partner Benjamin Leisinger (pictured left) and counsel Lee Saladino (pictured right) co-led the firm’s team, working alongside associate Daniel Hulmann (all capital markets) and partner Stefan Oesterhelt (tax).
